These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
501 related articles for article (PubMed ID: 27422717)
1. Inhibiting TLR2 activation attenuates amyloid accumulation and glial activation in a mouse model of Alzheimer's disease. McDonald CL; Hennessy E; Rubio-Araiz A; Keogh B; McCormack W; McGuirk P; Reilly M; Lynch MA Brain Behav Immun; 2016 Nov; 58():191-200. PubMed ID: 27422717 [TBL] [Abstract][Full Text] [Related]
2. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease. Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075 [TBL] [Abstract][Full Text] [Related]
3. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease. Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846 [TBL] [Abstract][Full Text] [Related]
4. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037 [TBL] [Abstract][Full Text] [Related]
5. Geniposidic acid ameliorates spatial learning and memory deficits and alleviates neuroinflammation via inhibiting HMGB-1 and downregulating TLR4/2 signaling pathway in APP/PS1 mice. Zhou Z; Hou J; Mo Y; Ren M; Yang G; Qu Z; Hu Y Eur J Pharmacol; 2020 Feb; 869():172857. PubMed ID: 31837991 [TBL] [Abstract][Full Text] [Related]
6. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model. Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926 [TBL] [Abstract][Full Text] [Related]
7. Early minor stimulation of microglial TLR2 and TLR4 receptors attenuates Alzheimer's disease-related cognitive deficit in rats: behavioral, molecular, and electrophysiological evidence. Pourbadie HG; Sayyah M; Khoshkholgh-Sima B; Choopani S; Nategh M; Motamedi F; Shokrgozar MA Neurobiol Aging; 2018 Oct; 70():203-216. PubMed ID: 30031930 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. Richard KL; Filali M; Préfontaine P; Rivest S J Neurosci; 2008 May; 28(22):5784-93. PubMed ID: 18509040 [TBL] [Abstract][Full Text] [Related]
9. FTY720 Attenuates Infection-Induced Enhancement of Aβ Accumulation in APP/PS1 Mice by Modulating Astrocytic Activation. McManus RM; Finucane OM; Wilk MM; Mills KHG; Lynch MA J Neuroimmune Pharmacol; 2017 Dec; 12(4):670-681. PubMed ID: 28620801 [TBL] [Abstract][Full Text] [Related]
10. APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease. Manocha GD; Floden AM; Rausch K; Kulas JA; McGregor BA; Rojanathammanee L; Puig KR; Puig KL; Karki S; Nichols MR; Darland DC; Porter JE; Combs CK J Neurosci; 2016 Aug; 36(32):8471-86. PubMed ID: 27511018 [TBL] [Abstract][Full Text] [Related]
11. Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice. Liu L; Liu Y; Li N; Huang R; Zheng X; Huang L; Hou S; Yuan Q Brain Res Bull; 2020 Mar; 156():86-104. PubMed ID: 31931120 [TBL] [Abstract][Full Text] [Related]
12. Characterization of astrocytes throughout life in wildtype and APP/PS1 mice after early-life stress exposure. Abbink MR; Kotah JM; Hoeijmakers L; Mak A; Yvon-Durocher G; van der Gaag B; Lucassen PJ; Korosi A J Neuroinflammation; 2020 Mar; 17(1):91. PubMed ID: 32197653 [TBL] [Abstract][Full Text] [Related]
13. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance. Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458 [TBL] [Abstract][Full Text] [Related]
14. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models. Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S Elife; 2020 Jun; 9():. PubMed ID: 32510331 [TBL] [Abstract][Full Text] [Related]
15. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease. Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574 [TBL] [Abstract][Full Text] [Related]
16. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model. Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064 [TBL] [Abstract][Full Text] [Related]
17. Long-term treadmill exercise attenuates Aβ burdens and astrocyte activation in APP/PS1 mouse model of Alzheimer's disease. Zhang J; Guo Y; Wang Y; Song L; Zhang R; Du Y Neurosci Lett; 2018 Feb; 666():70-77. PubMed ID: 29246793 [TBL] [Abstract][Full Text] [Related]
18. Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP/PS1 mice. McIntosh A; Mela V; Harty C; Minogue AM; Costello DA; Kerskens C; Lynch MA Brain Pathol; 2019 Sep; 29(5):606-621. PubMed ID: 30661261 [TBL] [Abstract][Full Text] [Related]
19. Flavonoid-rich ethanol extract from the leaves of Diospyros kaki attenuates cognitive deficits, amyloid-beta production, oxidative stress, and neuroinflammation in APP/PS1 transgenic mice. Ma Y; Ma B; Shang Y; Yin Q; Hong Y; Xu S; Shen C; Hou X; Liu X Brain Res; 2018 Jan; 1678():85-93. PubMed ID: 29038004 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology. Schmöle AC; Lundt R; Toporowski G; Hansen JN; Beins E; Halle A; Zimmer A J Alzheimers Dis; 2018; 64(2):379-392. PubMed ID: 29865078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]